HRP20181178T1 - Anti-androgeni peptidi i njihova uporaba za terapiju raka - Google Patents

Anti-androgeni peptidi i njihova uporaba za terapiju raka

Info

Publication number
HRP20181178T1
HRP20181178T1 HRP20181178TT HRP20181178T HRP20181178T1 HR P20181178 T1 HRP20181178 T1 HR P20181178T1 HR P20181178T T HRP20181178T T HR P20181178TT HR P20181178 T HRP20181178 T HR P20181178T HR P20181178 T1 HRP20181178 T1 HR P20181178T1
Authority
HR
Croatia
Prior art keywords
androgenic
peptides
cancer therapy
cancer
therapy
Prior art date
Application number
HRP20181178TT
Other languages
English (en)
Croatian (hr)
Inventor
Ferdinando Auricchio
Antimo Migliaccio
Original Assignee
Cancer Research Technology Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39766539&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20181178(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cancer Research Technology Limited filed Critical Cancer Research Technology Limited
Publication of HRP20181178T1 publication Critical patent/HRP20181178T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
HRP20181178TT 2007-03-16 2008-03-14 Anti-androgeni peptidi i njihova uporaba za terapiju raka HRP20181178T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89542407P 2007-03-16 2007-03-16
EP08717866.1A EP2139917B1 (en) 2007-03-16 2008-03-14 Anti-androgen peptides and uses thereof in cancer therapy
PCT/EP2008/053127 WO2008113770A2 (en) 2007-03-16 2008-03-14 Anti-androgen peptides and uses thereof in cancer therapy

Publications (1)

Publication Number Publication Date
HRP20181178T1 true HRP20181178T1 (hr) 2018-12-14

Family

ID=39766539

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20181178TT HRP20181178T1 (hr) 2007-03-16 2008-03-14 Anti-androgeni peptidi i njihova uporaba za terapiju raka

Country Status (15)

Country Link
US (3) US20100189776A1 (cg-RX-API-DMAC7.html)
EP (2) EP2139917B1 (cg-RX-API-DMAC7.html)
JP (4) JP5464344B2 (cg-RX-API-DMAC7.html)
AU (1) AU2008228274B2 (cg-RX-API-DMAC7.html)
CY (1) CY1120436T1 (cg-RX-API-DMAC7.html)
DK (1) DK2139917T3 (cg-RX-API-DMAC7.html)
ES (1) ES2677566T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20181178T1 (cg-RX-API-DMAC7.html)
HU (1) HUE039249T2 (cg-RX-API-DMAC7.html)
LT (1) LT2139917T (cg-RX-API-DMAC7.html)
PL (1) PL2139917T3 (cg-RX-API-DMAC7.html)
PT (1) PT2139917T (cg-RX-API-DMAC7.html)
SI (1) SI2139917T1 (cg-RX-API-DMAC7.html)
TR (1) TR201809422T4 (cg-RX-API-DMAC7.html)
WO (1) WO2008113770A2 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100189776A1 (en) 2007-03-16 2010-07-29 Cancer Research Technology Ltd Anti-androgen peptides and uses thereof in cancer therapy
GB2496135B (en) * 2011-11-01 2015-03-18 Valirx Plc Inhibitors of the interaction between a Src family kinase and an androgen receptor or estradiol receptor for treatment of endometriosis
GB2513615A (en) * 2013-05-01 2014-11-05 Cancer Rec Tech Ltd Medical use
WO2014188775A1 (ja) * 2013-05-23 2014-11-27 国立大学法人東北大学 アンドロゲンレセプター活性依存性乳癌細胞株の作製方法、当該細胞株を用いたスクリーニング方法、ならびに乳癌患者におけるアンドロゲンレセプター活性依存性獲得の判定方法、キット及びマーカー
KR102417496B1 (ko) * 2019-11-29 2022-07-06 (주)수파드엘릭사 안드로겐 수용체의 활성을 억제하는 폡타이드 및 이를 이용하는 화장료 조성물
WO2021244964A1 (en) 2020-06-01 2021-12-09 Black Cat Bio Limited Compositions and methods for treating infections and netopathy
EP4472743A4 (en) * 2022-02-04 2025-11-19 Hbc Immunology Inc MEDICINAL USES OF OLIGOPEPTIDES IN COMBINATION WITH AN ANTIANDROGEN

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998046250A1 (en) * 1997-04-14 1998-10-22 The Regents Of The University Of California Peptide antiestrogen compositions and methods for treating breast cancer
AU4494399A (en) 1998-06-30 2000-01-24 University Of British Columbia, The Inhibitors of androgen-independent activation of androgen receptor
EP1379550B1 (en) * 2000-12-21 2009-03-11 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences
US7060463B2 (en) * 2001-05-08 2006-06-13 Merck & Co., Inc. DNA molecules encoding Macaca mulatta androgen receptor
US7160989B2 (en) * 2003-05-30 2007-01-09 New York University Antibodies that recognize and bind phosphorylated human androgen receptor and methods of using same
US20100286229A1 (en) * 2005-09-30 2010-11-11 Katerina Gurova Modulation of Androgen Receptor for Treatment of Prostate Cancer
US20100189776A1 (en) * 2007-03-16 2010-07-29 Cancer Research Technology Ltd Anti-androgen peptides and uses thereof in cancer therapy

Also Published As

Publication number Publication date
EP2139917B1 (en) 2018-04-25
JP2019150029A (ja) 2019-09-12
US20100189776A1 (en) 2010-07-29
JP5464344B2 (ja) 2014-04-09
WO2008113770A3 (en) 2009-02-12
EP2139917A2 (en) 2010-01-06
SI2139917T1 (sl) 2018-10-30
US20180271933A1 (en) 2018-09-27
EP3412685A1 (en) 2018-12-12
JP6545122B2 (ja) 2019-07-17
DK2139917T3 (en) 2018-07-23
US20150202249A1 (en) 2015-07-23
JP2010521441A (ja) 2010-06-24
JP6689430B2 (ja) 2020-04-28
ES2677566T3 (es) 2018-08-03
US9919023B2 (en) 2018-03-20
HUE039249T2 (hu) 2018-12-28
LT2139917T (lt) 2018-07-10
JP2014087363A (ja) 2014-05-15
JP5998161B2 (ja) 2016-09-28
US11560406B2 (en) 2023-01-24
JP2016175927A (ja) 2016-10-06
TR201809422T4 (tr) 2018-07-23
PL2139917T3 (pl) 2018-09-28
AU2008228274A1 (en) 2008-09-25
PT2139917T (pt) 2018-07-18
WO2008113770A2 (en) 2008-09-25
AU2008228274B2 (en) 2013-04-18
CY1120436T1 (el) 2019-07-10

Similar Documents

Publication Publication Date Title
PL2567707T3 (pl) Kompozycja peptydów związanych z guzem i pokrewna szczepionka przeciw rakowi
BR112012004281A2 (pt) uso de metformina tratamento e prevenção de câncer
IL220386B (en) Compositions for the liquidation of tumors and uses thereof
BRPI0821779A2 (pt) tratamento terapêutico de câncer
BRPI0821660A2 (pt) Combinações de agentes terapêuticos para tratamento de câncer
SMT201600430B (it) Inibitori di chinasi e loro uso nel trattamento del cancro
HRP20180660T1 (hr) Sustavi i postupci za liječenje tkiva prostate
DK2473510T3 (da) Jak-2-hæmmere og anvendelse heraf til behandling af myeloproliferativesygdomme og cancer
LT3192529T (lt) Amatoksinu užtaisyti terapiniai su ląstelės paviršiumi susirišantys komponentai, sukonstruoti navikų terapijai
BRPI0919238A2 (pt) métodos e composições para o tratamento de câncer
DK2121139T3 (da) Formulations for cancer treatment
GB0718167D0 (en) Cancer marker and therapeutic target
DK2235002T3 (da) 4-pyridinonforbindelser og anvendelse heraf til behandling af cancer
BRPI1007972A2 (pt) composições de combinação e métodos para o tratamento de câncer
SMT201700056B (it) Fosfaplatine e relativo utilizzo per il trattamento di cancro
BRPI0810816A2 (pt) Medicamento e métodos para tratar doenças auto-imune e câncer
EP2283862A4 (en) ANTITUMOR AGENT
BRPI0818766A2 (pt) N-fenil-pirrolidinilmetilpirrolidinamidas substituídas e uso terapêutico das mesmas
BRPI0919857A2 (pt) tratamentos para cancer com radiacao e imunocitocinas
EP2147122A4 (en) ENZYMATIC ANTICANCER THERAPY
EP2123266A4 (en) THERAPEUTIC CANCER AND ANTI-CARCINOGENIC AGENT
BRPI0812932A2 (pt) Composições e métodos de tratar câncer
HRP20181178T1 (hr) Anti-androgeni peptidi i njihova uporaba za terapiju raka
PL2187967T3 (pl) Sposoby i kompozycje do leczenia raka
HUE038563T2 (hu) Rák kezelési eljárás